Business · 1 sources covering this

Emcure Pharma Q2FY27 results: Net profit rises 29.31% to ₹325 crore

The company recorded a strong 34 per cent growth in international business to ₹1,665.2 crore during the quarter while its domestic business rose 11.1 per cent to ₹1,155.3 crore

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Business StandardCenter·1h ago
Emcure Pharma Q2FY27 results: Net profit rises 29.31% to ₹325 crore
The company recorded a strong 34 per cent growth in international business to ₹1,665.2 crore during the quarter while its domestic business rose 11.1 per cent to ₹1,155.3 crore
Read at Business Standard →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/d0f3da687702a36f16f0dd18483be1669e718f40"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Emcure Pharma Q2FY27 results: Net profit rises 29.31% to ₹325 crore"></iframe>

Emcure Pharma Q2FY27 results: Net profit rises 29.31% to ₹325 crore

How 1 sources are covering this

Emcure Pharma Q2FY27 results: Net profit rises 29.31% to ₹325 crore

More from Business

Shah Rukh Khan's King: 5 big highlights of the superstar's biggest film yet

IndiGo CEO seeks lower Mumbai airport charges after Terminal 1 revamp

Delhi AQI reaches 331 on Nov 3 while some stations cross 400: Which areas are worst affected today?

TaMo-Iveco to create world's 4th largest CV group with ₹2.28 trn revenue

Reader

Trust & legal

Across the network